Original Research
Published on 29 Nov 2022
Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
in Infectious Diseases: Pathogenesis and Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1067516
- 4,336 views
- 23 citations

